Growing community of inventors

Gerpinnes, Belgium

Alain Matagne

Average Co-Inventor Count = 6.32

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 54

Alain MatagnePhilippe Michel (6 patents)Alain MatagneEdmond Differding (6 patents)Alain MatagnePatrice Talaga (6 patents)Alain MatagnePatrick Pasau (6 patents)Alain MatagneBenoît Kenda (4 patents)Alain MatagneBénédicte Lallemand (4 patents)Alain MatagneBénédicte Lallemand (2 patents)Alain MatagneBenoît Kenda (2 patents)Alain MatagneHenrik Klitgaard (1 patent)Alain MatagneTony Waegemans (1 patent)Alain MatagneAlain Matagne (7 patents)Philippe MichelPhilippe Michel (18 patents)Edmond DifferdingEdmond Differding (15 patents)Patrice TalagaPatrice Talaga (9 patents)Patrick PasauPatrick Pasau (7 patents)Benoît KendaBenoît Kenda (18 patents)Bénédicte LallemandBénédicte Lallemand (5 patents)Bénédicte LallemandBénédicte Lallemand (2 patents)Benoît KendaBenoît Kenda (2 patents)Henrik KlitgaardHenrik Klitgaard (1 patent)Tony WaegemansTony Waegemans (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ucb S.a. (5 from 119 patents)

2. Ucb Pharma, S.a. (1 from 179 patents)

3. Uob Pharma, S.a. (1 from 1 patent)


7 patents:

1. 8034958 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

2. 7692028 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

3. 7358276 - 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

4. 6911461 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

5. 6903130 - Pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders

6. 6806287 - 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses

7. 6784197 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…